David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOTAU
2626
DELISTED
Draper Oakwood Technology Acquisition, Inc. Unit
DOTAU
| $767K | ﹤0.01% |
+75,000
| New | +$762K |
|
2627
CALL
Hyster-Yale Materials Handling
HY
$615M
| $764K | ﹤0.01% |
10,000
| – | – |
|
2628
Standard BioTools
LAB
$256M
| $764K | ﹤0.01% |
151,651
+69,876
| +85% | +$294K |
|
2629
PUT
Twilio
TWLO
$34.5B
| $764K | ﹤0.01% |
25,600
-24,400
| -49% | -$732K |
|
2630
CALL
Alaska Air
ALK
$4.73B
| $763K | ﹤0.01% |
10,000
-38,400
| -79% | -$3.14M |
|
|
SFE
2631
DELISTED
Safeguard Scientifics, Inc.
SFE
| $762K | ﹤0.01% |
57,087
+281
| +0.5% | +$3.46K |
|
|
SIR
2632
DELISTED
SELECT INCOME REIT
SIR
| $761K | ﹤0.01% |
+73,928
| New | +$759K |
|
|
ZGNX
2633
DELISTED
Zogenix, Inc.
ZGNX
| $761K | ﹤0.01% |
21,707
-5,248
| -19% | -$71.2K |
|
|
GNC
2634
DELISTED
GNC Holdings, Inc.
GNC
| $760K | ﹤0.01% |
86,006
-31,174
| -27% | -$280K |
|
|
VVC
2635
DELISTED
Vectren Corporation
VVC
| $759K | ﹤0.01% |
11,541
-47,176
| -80% | -$2.95M |
|
2636
Artivion
AORT
$1.29B
| $757K | ﹤0.01% |
33,350
-25,215
| -43% | -$508K |
|
2637
CALL
Herc Holdings
HRI
$5.29B
| $757K | ﹤0.01% |
15,400
-1,700
| -10% | -$73.7K |
|
2638
PUT
Lumen
LUMN
$5.9B
| $756K | ﹤0.01% |
+40,000
| New | +$842K |
|
|
TNAV
2639
DELISTED
Telenav Inc.
TNAV
| $756K | ﹤0.01% |
118,994
+31,202
| +36% | +$217K |
|
2640
CALL
Range Resources
RRC
$9.6B
| $755K | ﹤0.01% |
38,600
| – | – |
|
|
FRAN
2641
DELISTED
Francesca's Holdings Corporation
FRAN
| $755K | ﹤0.01% |
8,554
+4,512
| +112% | +$457K |
|
|
AVNS
2642
DELISTED
Avanos Medical
AVNS
| $754K | ﹤0.01% |
16,738
-52,906
| -76% | -$2.26M |
|
2643
Columbia Sportswear
COLM
$3.04B
| $749K | ﹤0.01% |
12,171
+13
| +0.1% | +$754 |
|
|
CRZO
2644
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $744K | ﹤0.01% |
43,407
-122,097
| -74% | -$1.78M |
|
|
KYO
2645
DELISTED
Kyocera Adr
KYO
| $744K | ﹤0.01% |
11,961
+3,398
| +40% | +$204K |
|
2646
PUT
AngloGold Ashanti
AU
$61B
| $743K | ﹤0.01% |
80,000
| – | – |
|
2647
CALL
Huntsman Corp
HUN
$1.67B
| $743K | ﹤0.01% |
27,100
+7,100
| +36% | +$189K |
|
2648
Peabody Energy
BTU
$3.34B
| $741K | ﹤0.01% |
+25,526
| New | +$720K |
|
|
DNKN
2649
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $740K | ﹤0.01% |
13,936
-258,474
| -95% | -$13.7M |
|
|
MGI
2650
PUT
DELISTED
MoneyGram International, Inc. New
MGI
| $738K | ﹤0.01% |
45,800
| – | – |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.